Free Trial
NASDAQ:EFTR

eFFECTOR Therapeutics (EFTR) Stock Price, News & Analysis

eFFECTOR Therapeutics logo
$0.0002 0.00 (-33.33%)
As of 07/3/2025 09:43 AM Eastern

About eFFECTOR Therapeutics Stock (NASDAQ:EFTR)

Key Stats

Today's Range
$0.0002
$0.0006
50-Day Range
N/A
52-Week Range
$0.00
$0.16
Volume
800 shs
Average Volume
3,172 shs
Market Capitalization
$940.80
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EFTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for eFFECTOR Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

EFTR Stock News Headlines

Gold is soaring. Here’s how to get paid from it
Gold just broke through $3,300… And while the headlines shout about price targets, something even more powerful is happening behind the scenes… Some investors are using a little-known ETF to collect up to $1,152/month from gold's surge. No trading gold futures. No mining stocks. No vaults. Just a simple fund delivering monthly payouts — like clockwork.
See More Headlines

EFTR Stock Analysis - Frequently Asked Questions

eFFECTOR Therapeutics' stock was trading at $0.0002 at the start of the year. Since then, EFTR shares have increased by 0.0% and is now trading at $0.0002.

eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR) released its quarterly earnings data on Monday, November, 8th. The company reported $10.50 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($6.50) by $17.00. The company earned $0.43 million during the quarter.

eFFECTOR Therapeutics's stock reverse split on Friday, January 12th 2024.The 1-25 reverse split was announced on Friday, January 12th 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, January 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Shares of EFTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that eFFECTOR Therapeutics investors own include HubSpot (HUBS), Netflix (NFLX), Tesla (TSLA), Athenex (ATNX), ForgeRock (FORG) and Plug Power (PLUG).

Company Calendar

Last Earnings
11/08/2021
Today
7/04/2025
Next Earnings (Estimated)
7/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:EFTR
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
($1.94) per share
Price / Book
0.00

Miscellaneous

Free Float
4,483,000
Market Cap
$940.80
Optionable
No Data
Beta
0.97
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (NASDAQ:EFTR) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners